Delivery Order SPE2DB24D2101-SPE2DB24FKFTQ

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 ml-Dextroses. The contract has a total ceiling value of $2,112.53 and is a firm fixed price delivery order with an ultimate completion date of August 20, 2024. The contract was awarded on August 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.46, is for the delivery of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The contract has a firm fixed price pricing type and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 g/50 ml-dextrose, a pharmaceutical product. The fixed-price contract has a ceiling value of $2,411.23 and a period of performance through June 23, 2025. This order is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,387.34, is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract is a firm-fixed-price, non-set-aside delivery order with a completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $4,335.84 and an ultimate completion date of August 13, 2024. It is a firm fixed-price contract, with no set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a Firm Fixed Price Delivery Order for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,662,455 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a ceiling value of $15,175.44 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.28 firm fixed-price contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a generic antibiotic medication, to support military healthcare programs. The delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Cefazolin 2 g/50 ml-Dextroses, a critical medical product, with a ceiling value of $2,574.17 and a performance period through February 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of cefazolin 2 g/50 ml-dextroses, a critical care medication, with a ceiling value of $21,285.04 and a completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFTQ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 mL-dextrose medication. The contract has a ceiling value of $2,123.62 and is a firm fixed-price delivery order that runs through August 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/6/24, 9:12 AM